The DOE IP invites you to join us for virtual "one-on-one" stakeholder meetings on Oct. 19, Oct. 24 and Oct. 26, 2023.
NIDC News
The Department of Energy Isotope Program (DOE IP) invites you to join us for virtual "one-on-one" stakeholder meetings on Oct. 19, Oct. 24 and Oct. 26, 2023.
The Department of Energy Isotope Program will host three medical isotope virtual seminars focused on the following emerging alpha and beta emitters: astatine-211, lead-203/212, and cerium-134.
Funding Part of DOE’s Commitment to Supporting Next Generation of America’s STEM Leaders
DOE Isotope Program Highlights
Scientists Identify an Alternative System for Producing the Medical Isotope Scandium-44
An easy-to-use system can increase the availability of PET imaging agents to more patients.
Researchers Improve Production for Short-Lived Scandium Radioisotopes
Hard to produce in quantities and purities appropriate for human use, scandium radioisotopes have potential for imaging cancer.
Tunable Bonds: A Step Towards Targeted At-211 Cancer Therapy
Scientists can tune the strength of astatine-211 bonds with chemicals called ketones, laying the groundwork for a new class of radiopharmaceuticals.
![Image courtesy of Brown, M.A., Metal Oxide Sorbents for the Separation of Radium and Actinium, Industrial & Engineering Chemistry Research, 59, 20472-20477 (2020). [DOI: 10.1021/acs.iecr.0c04084] The separation of radium and actinium is a major component in the production, distribution, and purity of targeted alpha therapy isotopes. This image shows the separation profiles of radium (purple) and actinium (green) across a zirconia resin.](/sites/default/files/styles/center_news_homepage/public/2023-07/ip-2023-05-b_original.png?h=c508fa7a&itok=OY-0g7A7)
Scientists Develop Inorganic Resins for Generating and Purifying Radium and Actinium
Research advances the chemistry and improves the purity of isotopes for targeted alpha therapy used in the treatment of cancers.
